EN
EN
FR
ES
PT
AR
RU
DE
IT
NL
TH
KO
VI
ID
Home
Kexing Biopharm
About Us
Kexing Brand
Brand Connotation
Corporate Culture
Honors
History
Global Business
Global Commercial Cooperation Strategy
Commercialization platform
Commercialization capability
Commercial Cooperation Graph
R&D and Innovation
Global R&D Center
R&D field
Animal Vaccine
Synthetic Biology
SANCTINUS
Our Medicines
Infliximab for Injection
Bevacizumab Injection
Adalimumab Solution for Injection
Paclitaxel for Injection(Albumin-Bound)
Human Erythropoietin Injection
Human Granulocyte Colony-stimulating Factor Injection
Combined Clostridium Butyricum and Bifidobacterium Capsule, Live
Human Interferon α1b for Injection
Kehuang Capsule
Entecavir Tablets
α-ketoglutarate(AKG)
5-aminnolevulinic acid (5-ALA)
Recombinant Collagen Repair Mask
Recombinant Collagen Anti-Wrinkle Single Use Essence
Aflibercept Intravitreous Injection
Denosumab
Enzalutamide Soft Capsules
Sitagliptin Phosphate Tablets
Liraglutide Injection
Sevelamer Carbonate Tablets
Olaparib Tablets
Sorafenib Tablets
Eribulin Mesylate Injection
Neratinib Maleate Tablets
Lenalidomide Capsules
Trastuzumab Injection
Palbociclib Capsules
Semaglutide Injection
Quality Control
Quality system
Compliant production
Pharmacovigilance
ESG
Global health
Support Community
Environmental protection
News
News and Innovation
Blogs
Video Center
Contact
Contact Us
Join Us
NEWS AND INFORMATION
Home
/
Kexing Biopharm...
Kexing Biopharm Product Introduction-20251023
Article source:
Oct 22,2025
View: 470
LABEL:
< Kexing Biopharm's Product Introduction 20251021
Kexing Biopharm Product List-20251023 >
BACK TO LIST
Related News
Nov 04,2024
Harnessing the Power of Recombinant Collagen Repair Mask for Youthful Skin
READ MORE >>
Aug 12,2025
Creating High-Value Biopharma Partnerships: The Technology & Service Synergy of Kexing Biopharm
READ MORE >>
Dec 12,2023
Navigating the Global Landscape: The Rise of Chinese Biological Products Exporters
READ MORE >>
Jun 06,2024
Kexing Biopharm Obtained Clinical Trial Approval for its Self-developed Class I Innovative Drug--Long-acting Growth Hormone
READ MORE >>
Sep 28,2023
Adalimumab Biosimilars: Advancing Healthcare Access with Kexing Biopharm
READ MORE >>
May 07,2025
How Is Kexing Biopharm Leading the Charge as an Innovative Biopharmaceutical Enterprise?
READ MORE >>
Home
Kexing Biopharm
About Us
Kexing Brand
Brand Connotation
Corporate Culture
Honors
History
Global Business
Global Commercial Cooperation Strategy
Commercialization platform
Commercialization capability
Commercial Cooperation Graph
R&D and Innovation
Global R&D Center
R&D field
Animal Vaccine
Synthetic Biology
SANCTINUS
Our Medicines
Infliximab for Injection
Bevacizumab Injection
Adalimumab Solution for Injection
Paclitaxel for Injection(Albumin-Bound)
Human Erythropoietin Injection
Human Granulocyte Colony-stimulating Factor Injection
Combined Clostridium Butyricum and Bifidobacterium Capsule, Live
Human Interferon α1b for Injection
Kehuang Capsule
Entecavir Tablets
α-ketoglutarate(AKG)
5-aminnolevulinic acid (5-ALA)
Recombinant Collagen Repair Mask
Recombinant Collagen Anti-Wrinkle Single Use Essence
Aflibercept Intravitreous Injection
Denosumab
Enzalutamide Soft Capsules
Sitagliptin Phosphate Tablets
Liraglutide Injection
Sevelamer Carbonate Tablets
Olaparib Tablets
Sorafenib Tablets
Eribulin Mesylate Injection
Neratinib Maleate Tablets
Lenalidomide Capsules
Trastuzumab Injection
Palbociclib Capsules
Semaglutide Injection
Quality Control
Quality system
Compliant production
Pharmacovigilance
ESG
Global health
Support Community
Environmental protection
News
News and Innovation
Blogs
Video Center
Contact
Contact Us
Join Us